This question has been answered by the relevant Government Department.
Lord Mendelsohn to ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 6 July (HL964), what plans they have to develop specific clinical guidance for the treatment of people who are immunocompromised or immunosuppressed and become infected with COVID-19. HL2091
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
Member's Registered Interests
There are no interests to show.